TARGETING THE RB PATHWAY IN MEDULLOBLASTOMA

Archive ouverte

Jonchere, Barbara | Stripay, Jennifer | Pribnow, Allison | Zindy, Frederique | Min, Jaeki | Freeman, Burgess | Shelat, Anang | Rankovic, Zoran | Roussel, Martine

Edité par CCSD ; Oxford University Press (OUP) -

24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS, Phoenix, AZ, NOV 20-24, 2019. International audience

Consulter en ligne

Suggestions

Du même auteur

Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs

Archive ouverte | Min, Jaeki | CCSD

International audience. Targeting cereblon (CRBN) is currently one of the most frequently reported proteolysis-targeting chimera (PROTAC) approaches, owing to favorable drug-like properties of CRBN ligands, immunomo...

Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators

Archive ouverte | Nishiguchi, Gisele | CCSD

International audience. Whereas the PROTAC approach to target protein degradation greatly benefits from rational design, the discovery of small-molecule degraders relies mostly on phenotypic screening and retrospect...

Small-Molecule Screen Reveals Synergy of Cell Cycle Checkpoint Kinase Inhibitors with DNA-damaging Chemotherapies in Medulloblastoma

Archive ouverte | Endersby, Raelene | CCSD

International audience. Medulloblastoma (MB) consists of four core molecular subgroups with distinct clinical features and prognoses. Treatment consists of surgery, followed by radiotherapy and cytotoxic chemotherap...

Chargement des enrichissements...